BioLine Rx Ltd (BLRX)
0.3232
-0.22
(-40.71%)
USD |
NASDAQ |
Nov 21, 16:00
0.325
0.00 (0.00%)
Pre-Market: 08:42
BioLine Rx Profit Margin (Quarterly): 8.97% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 8.97% |
March 31, 2024 | -10.15% |
December 31, 2023 | -289.2% |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 |
Date | Value |
---|---|
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-289.2%
Minimum
Dec 2023
8.97%
Maximum
Jun 2024
-96.81%
Average
-10.15%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
Compugen Ltd | 7.45% |
Pluri Inc | -1.80K% |
XTL Biopharmaceuticals Ltd | -- |
Can Fite Biofarma Ltd | -1.07K% |
BiomX Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -202.3% |
Return on Assets | -51.59% |
Return on Invested Capital | -102.9% |
Gross Profit Margin (Quarterly) | 83.37% |
Operating Margin (Quarterly) | -107.0% |
Return on Net Operating Assets | -120.4% |